M&A Deal Summary

Santen Pharmaceutical Acquires InnFocus

On July 19, 2016, Santen Pharmaceutical acquired medical products company InnFocus for 225M USD

Acquisition Highlights
  • This is Santen Pharmaceutical’s 1st transaction in the Medical Products sector.
  • This is Santen Pharmaceutical’s largest (disclosed) transaction.
  • This is Santen Pharmaceutical’s 1st transaction in the United States.
  • This is Santen Pharmaceutical’s 1st transaction in Florida.

M&A Deal Summary
Date 2016-07-19
Target InnFocus
Sector Medical Products
Buyer(s) Santen Pharmaceutical
Deal Type Add-on Acquisition
Deal Value 225M USD

Target

InnFocus

Miami, Florida, United States
InnFocus, Inc. is a developer of the InnFocus MicroShunt® (hereinafter, "MicroShunt") glaucoma implant device.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Santen Pharmaceutical

Osaka, Japan
Category Company
Founded 1890
Sector Life Science
Employees3,744
Revenue 302.0B JPY (2024)
DESCRIPTION

Santen Pharmaceutical is an entity which engages in the research, development, manufacture, and marketing of ophthalmic and anti-rheumatic pharmaceuticals for the protection and enhancement of eyesight and health. Santen Pharmaceutical was founded in 1890 and is based in Osaka, Japan.

DEAL STATS #
Overall 2 of 3
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 2 of 3
State (Florida) 1 of 1
Country (United States) 1 of 2
Year (2016) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-11 Novagali Pharma SA

Evry, France

Novagali Pharma SA is a biopharmaceutical company specializing in ophthalmology.

Buy €102M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-16 Eyevance Pharmaceuticals

Fort Worth, Texas, United States

Eyevance Pharmaceuticals is committed to developing and commercializing innovative and impactful ophthalmic products that enable optimal vision, better quality of life, and address significant unmet medical needs. Eyevance Pharmaceuticals was founded in 2017 and is based in Fort Worth, Texas.

Buy -
Mergr

Product

Company

Legal